Compounds > estrone-3-o-sulfamate
Page last updated: 2024-09-03

estrone-3-o-sulfamate and entrectinib

estrone-3-o-sulfamate has been researched along with entrectinib in 1 studies

Compound Research Comparison

Studies
(estrone-3-o-sulfamate)		Trials
(estrone-3-o-sulfamate)		Recent Studies (post-2010)
(estrone-3-o-sulfamate)		Studies
(entrectinib)		Trials
(entrectinib)		Recent Studies (post-2010) (entrectinib)
890151427140

Protein Interaction Comparison

ProteinTaxonomyestrone-3-o-sulfamate (IC50)entrectinib (IC50)
Aurora kinase AHomo sapiens (human)0.215
Tyrosine-protein kinase JAK2Homo sapiens (human)0.04
High affinity nerve growth factor receptorHomo sapiens (human)0.0059
Insulin receptorHomo sapiens (human)0.209
Proto-oncogene tyrosine-protein kinase receptor RetHomo sapiens (human)0.393
Insulin-like growth factor 1 receptorHomo sapiens (human)0.122
Proto-oncogene tyrosine-protein kinase ROSHomo sapiens (human)0.0072
Tyrosine-protein kinase JAK1Homo sapiens (human)0.112
Receptor-type tyrosine-protein kinase FLT3Homo sapiens (human)0.164
Tyrosine-protein kinase JAK3Homo sapiens (human)0.349
Focal adhesion kinase 1Homo sapiens (human)0.14
Activated CDC42 kinase 1Homo sapiens (human)0.07
Protein-tyrosine kinase 6Homo sapiens (human)0.195
NT-3 growth factor receptorHomo sapiens (human)0.0049
BDNF/NT-3 growth factors receptorHomo sapiens (human)0.0037
Serine/threonine-protein kinase LMTK3Homo sapiens (human)4.653
Echinoderm microtubule-associated protein-like 4Homo sapiens (human)0.3307
ALK tyrosine kinase receptorHomo sapiens (human)0.1075

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Han, KL; Jia, Y; Li, P; Qiao, Y; Zhang, MM1

Other Studies

1 other study(ies) available for estrone-3-o-sulfamate and entrectinib

ArticleYear
New Protocol-Guided Exploitation of a Lysosomal Sulfatase Inhibitor to Suppress Cell Growth in Glioblastoma Multiforme.
    Journal of medicinal chemistry, 2021, 06-24, Volume: 64, Issue:12

    Topics: Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Enzyme Inhibitors; Fluorescent Dyes; Glioblastoma; Glucosides; Humans; Lysosomes; Naphthalimides; Prognosis; Sulbactam; Sulfatases

2021